Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-26-052724
Filing Date
2026-08-04
Accepted
2026-08-04 17:11:27
Documents
14
Effectiveness Date
2026-08-04

Document Format Files

Seq Description Document Type Size
1 S-8 s-8esppplanregistrationaug.htm S-8 51056
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 19515
3 EX-5.1 s-8exhibit51august2026.htm EX-5.1 5634
4 EX-23.1 s-8exhibit231august2026.htm EX-23.1 1904
5 ASHURST PERKINS COIE LETTERHEAD ashurstperkinscoieletterhea.jpg GRAPHIC 68715
  Complete submission text file 0001628280-26-052724.txt   290497

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 4188
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-297971 | Film No.: 261240134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)